US Stock MarketDetailed Quotes

RGLS Regulus Therapeutics

Watchlist
  • 1.5900
  • +0.0400+2.58%
Close Dec 20 16:00 ET
  • 1.5900
  • 0.00000.00%
Post 20:01 ET
104.15MMarket Cap-1.56P/E (TTM)

Regulus Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-50.53%-9.45M
-86.13%-11.64M
-7.74%-8.74M
-4.87%-26.77M
2.05%-6.13M
6.77%-6.28M
-1.51%-6.25M
-27.16%-8.11M
-5.79%-25.53M
20.15%-6.25M
Net income from continuing operations
-79.73%-14.06M
-57.36%-11.04M
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.38%-7.01M
-6.25%-7.14M
-1.85%-28.32M
4.74%-6.8M
Depreciation and amortization
60.71%90K
89.36%89K
68.75%81K
86.07%227K
130.30%76K
75.00%56K
51.61%47K
84.62%48K
-73.42%122K
-19.51%33K
Other non cash items
--0
-80.00%10K
3.23%32K
6.02%141K
-12.50%28K
3.23%32K
56.25%50K
-18.42%31K
189.13%133K
357.14%32K
Change In working capital
401.68%2.69M
-758.16%-1.86M
-6.61%-1.5M
-53.27%257K
297.18%846K
25.76%537K
-55.66%282K
-93.94%-1.41M
-39.82%550K
115.03%213K
-Change in receivables
----
--0
--0
----
----
----
-87.50%1K
50.00%-4K
----
----
-Change in prepaid assets
852.48%1.52M
-1,370.39%-1.93M
-33.48%445K
856.72%507K
87.11%-112K
-7.45%-202K
-50.81%152K
-1.76%669K
-180.72%-67K
13.53%-869K
-Change in payables and accrued expense
188.03%674K
1,174.39%881K
103.34%20K
-247.88%-698K
-170.97%-252K
-25.71%234K
-159.42%-82K
-633.93%-598K
258.92%472K
94.81%-93K
-Change in other current liabilities
36.14%-53K
-433.94%-1.46M
45.62%-149K
-1,290.00%-238K
-42.63%393K
-692.86%-83K
19.17%-274K
19.41%-274K
-72.60%20K
-14.59%685K
-Change in other working capital
-5.47%553K
35.46%657K
-51.29%-1.82M
448.80%686K
66.73%817K
104.55%585K
-6.73%485K
-2.56%-1.2M
-77.36%125K
-15.08%490K
Cash from discontinued investing activities
Operating cash flow
-50.53%-9.45M
-86.13%-11.64M
-7.74%-8.74M
-4.87%-26.77M
2.05%-6.13M
6.77%-6.28M
-1.51%-6.25M
-27.16%-8.11M
-5.79%-25.53M
20.15%-6.25M
Investing cash flow
Cash flow from continuing investing activities
442.72%18.64M
-83K
-623.66%-78.54M
195.84%14.49M
-52.88%4.93M
57.70%-5.44M
0
14,804.90%15M
-5,923.90%-15.12M
25,629.27%10.47M
Net PPE purchase and sale
94.82%-28K
---83K
-22,800.00%-229K
-68.98%-610K
-7.94%-68K
-17,933.33%-541K
--0
99.02%-1K
-43.82%-361K
-53.66%-63K
Net investment purchase and sale
481.14%18.67M
--0
-622.10%-78.32M
202.32%15.1M
-52.52%5M
61.90%-4.9M
--0
--15M
---14.76M
--10.53M
Cash from discontinued investing activities
Investing cash flow
442.72%18.64M
---83K
-623.66%-78.54M
195.84%14.49M
-52.88%4.93M
57.70%-5.44M
--0
14,804.90%15M
-5,923.90%-15.12M
25,629.27%10.47M
Financing cash flow
Cash flow from continuing financing activities
-80.49%56K
-105.63%-744K
11,665.84%93.11M
163.10%11.82M
-873K
-93.61%287K
13.21M
-40,350.00%-805K
-91.64%4.49M
0
Net issuance payments of debt
--0
33.29%-551K
0.00%-826K
---3.3M
---826K
---826K
---826K
---826K
--0
--0
Net common stock issuance
-94.97%56K
-101.38%-194K
447,180.95%93.93M
236.67%15.12M
---47K
-75.21%1.11M
--14.03M
950.00%21K
-91.65%4.49M
--0
Proceeds from stock option exercised by employees
--0
--1K
--2K
----
----
--0
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-80.49%56K
-105.63%-744K
11,665.84%93.11M
163.10%11.82M
---873K
-93.61%287K
--13.21M
-40,350.00%-805K
-91.64%4.49M
--0
Net cash flow
Beginning cash position
-53.96%17.18M
-2.38%29.65M
-1.90%23.83M
-59.81%24.29M
28.98%25.9M
6.09%37.33M
-43.72%30.37M
-59.81%24.29M
94.44%60.45M
-44.09%20.08M
Current changes in cash
180.94%9.25M
-279.21%-12.46M
-4.29%5.82M
98.72%-461K
-149.03%-2.07M
24.33%-11.43M
137.03%6.96M
193.81%6.08M
-223.15%-36.16M
-82.82%4.21M
End cash Position
2.09%26.44M
-53.96%17.18M
-2.38%29.65M
-1.90%23.83M
-1.90%23.83M
28.98%25.9M
6.09%37.33M
-43.72%30.37M
-59.81%24.29M
-59.81%24.29M
Free cash flow
-39.00%-9.48M
-87.46%-11.72M
-10.55%-8.97M
-5.77%-27.38M
1.90%-6.2M
-1.22%-6.82M
1.57%-6.25M
-25.17%-8.12M
-6.19%-25.89M
19.77%-6.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -50.53%-9.45M-86.13%-11.64M-7.74%-8.74M-4.87%-26.77M2.05%-6.13M6.77%-6.28M-1.51%-6.25M-27.16%-8.11M-5.79%-25.53M20.15%-6.25M
Net income from continuing operations -79.73%-14.06M-57.36%-11.04M-18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.38%-7.01M-6.25%-7.14M-1.85%-28.32M4.74%-6.8M
Depreciation and amortization 60.71%90K89.36%89K68.75%81K86.07%227K130.30%76K75.00%56K51.61%47K84.62%48K-73.42%122K-19.51%33K
Other non cash items --0-80.00%10K3.23%32K6.02%141K-12.50%28K3.23%32K56.25%50K-18.42%31K189.13%133K357.14%32K
Change In working capital 401.68%2.69M-758.16%-1.86M-6.61%-1.5M-53.27%257K297.18%846K25.76%537K-55.66%282K-93.94%-1.41M-39.82%550K115.03%213K
-Change in receivables ------0--0-------------87.50%1K50.00%-4K--------
-Change in prepaid assets 852.48%1.52M-1,370.39%-1.93M-33.48%445K856.72%507K87.11%-112K-7.45%-202K-50.81%152K-1.76%669K-180.72%-67K13.53%-869K
-Change in payables and accrued expense 188.03%674K1,174.39%881K103.34%20K-247.88%-698K-170.97%-252K-25.71%234K-159.42%-82K-633.93%-598K258.92%472K94.81%-93K
-Change in other current liabilities 36.14%-53K-433.94%-1.46M45.62%-149K-1,290.00%-238K-42.63%393K-692.86%-83K19.17%-274K19.41%-274K-72.60%20K-14.59%685K
-Change in other working capital -5.47%553K35.46%657K-51.29%-1.82M448.80%686K66.73%817K104.55%585K-6.73%485K-2.56%-1.2M-77.36%125K-15.08%490K
Cash from discontinued investing activities
Operating cash flow -50.53%-9.45M-86.13%-11.64M-7.74%-8.74M-4.87%-26.77M2.05%-6.13M6.77%-6.28M-1.51%-6.25M-27.16%-8.11M-5.79%-25.53M20.15%-6.25M
Investing cash flow
Cash flow from continuing investing activities 442.72%18.64M-83K-623.66%-78.54M195.84%14.49M-52.88%4.93M57.70%-5.44M014,804.90%15M-5,923.90%-15.12M25,629.27%10.47M
Net PPE purchase and sale 94.82%-28K---83K-22,800.00%-229K-68.98%-610K-7.94%-68K-17,933.33%-541K--099.02%-1K-43.82%-361K-53.66%-63K
Net investment purchase and sale 481.14%18.67M--0-622.10%-78.32M202.32%15.1M-52.52%5M61.90%-4.9M--0--15M---14.76M--10.53M
Cash from discontinued investing activities
Investing cash flow 442.72%18.64M---83K-623.66%-78.54M195.84%14.49M-52.88%4.93M57.70%-5.44M--014,804.90%15M-5,923.90%-15.12M25,629.27%10.47M
Financing cash flow
Cash flow from continuing financing activities -80.49%56K-105.63%-744K11,665.84%93.11M163.10%11.82M-873K-93.61%287K13.21M-40,350.00%-805K-91.64%4.49M0
Net issuance payments of debt --033.29%-551K0.00%-826K---3.3M---826K---826K---826K---826K--0--0
Net common stock issuance -94.97%56K-101.38%-194K447,180.95%93.93M236.67%15.12M---47K-75.21%1.11M--14.03M950.00%21K-91.65%4.49M--0
Proceeds from stock option exercised by employees --0--1K--2K----------0--0--0--------
Cash from discontinued financing activities
Financing cash flow -80.49%56K-105.63%-744K11,665.84%93.11M163.10%11.82M---873K-93.61%287K--13.21M-40,350.00%-805K-91.64%4.49M--0
Net cash flow
Beginning cash position -53.96%17.18M-2.38%29.65M-1.90%23.83M-59.81%24.29M28.98%25.9M6.09%37.33M-43.72%30.37M-59.81%24.29M94.44%60.45M-44.09%20.08M
Current changes in cash 180.94%9.25M-279.21%-12.46M-4.29%5.82M98.72%-461K-149.03%-2.07M24.33%-11.43M137.03%6.96M193.81%6.08M-223.15%-36.16M-82.82%4.21M
End cash Position 2.09%26.44M-53.96%17.18M-2.38%29.65M-1.90%23.83M-1.90%23.83M28.98%25.9M6.09%37.33M-43.72%30.37M-59.81%24.29M-59.81%24.29M
Free cash flow -39.00%-9.48M-87.46%-11.72M-10.55%-8.97M-5.77%-27.38M1.90%-6.2M-1.22%-6.82M1.57%-6.25M-25.17%-8.12M-6.19%-25.89M19.77%-6.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data